AR020064A1 - Composicion farmaceutica que contiene una combinacion de una proteina osteoinductiva y un factor de dorsalizacion y metodo para su elaboracion. - Google Patents

Composicion farmaceutica que contiene una combinacion de una proteina osteoinductiva y un factor de dorsalizacion y metodo para su elaboracion.

Info

Publication number
AR020064A1
AR020064A1 ARP990101558A ARP990101558A AR020064A1 AR 020064 A1 AR020064 A1 AR 020064A1 AR P990101558 A ARP990101558 A AR P990101558A AR P990101558 A ARP990101558 A AR P990101558A AR 020064 A1 AR020064 A1 AR 020064A1
Authority
AR
Argentina
Prior art keywords
dorsalization
elaboration
combination
pharmaceutical composition
composition containing
Prior art date
Application number
ARP990101558A
Other languages
English (en)
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of AR020064A1 publication Critical patent/AR020064A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Composicion farmacéutica que contiene una combinacion de una proteína osteoinductora y un factor de dorsalizacion en una relacion de 10:1 a 1:10, es unagente farmacéutico de utilidad para la condrogénesis, y método para su elaboracion.
ARP990101558A 1998-04-08 1999-04-06 Composicion farmaceutica que contiene una combinacion de una proteina osteoinductiva y un factor de dorsalizacion y metodo para su elaboracion. AR020064A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98106404A EP0950414A1 (en) 1998-04-08 1998-04-08 Use of a combination of an osteoinductive protein and a dorsalizing factor for cartilage induction

Publications (1)

Publication Number Publication Date
AR020064A1 true AR020064A1 (es) 2002-04-10

Family

ID=8231737

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101558A AR020064A1 (es) 1998-04-08 1999-04-06 Composicion farmaceutica que contiene una combinacion de una proteina osteoinductiva y un factor de dorsalizacion y metodo para su elaboracion.

Country Status (10)

Country Link
EP (1) EP0950414A1 (es)
JP (1) JP2000053579A (es)
KR (1) KR19990082999A (es)
CN (1) CN1236645A (es)
AR (1) AR020064A1 (es)
AU (1) AU2359099A (es)
BR (1) BR9903179A (es)
CA (1) CA2267844A1 (es)
TR (1) TR199900748A2 (es)
ZA (1) ZA992570B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471891A1 (en) * 2001-12-27 2003-07-24 Dan Gazit Methods of inducing or enhancing connective tissue repair
JP2007507429A (ja) 2003-10-06 2007-03-29 モナシュ ユニバーシティー 治療方法
JPWO2012029148A1 (ja) * 2010-09-01 2013-10-28 株式会社オステオファーマ 組換えヒト骨形成タンパク質−２凍結乾燥製剤
CN107913436A (zh) * 2016-10-09 2018-04-17 刘英芹 作用于伤残组织原位的骨与软组织同步再生诱导剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434934D1 (de) * 1993-10-14 2007-04-12 Harvard College Verfahren zur induzierung und zur erhaltung neuronalen zellen
US5846770A (en) * 1994-11-22 1998-12-08 Genetics Institute, Inc. DNA molecules encoding human chordin

Also Published As

Publication number Publication date
AU2359099A (en) 1999-10-21
JP2000053579A (ja) 2000-02-22
ZA992570B (en) 1999-10-08
EP0950414A1 (en) 1999-10-20
CA2267844A1 (en) 1999-10-08
TR199900748A2 (xx) 1999-10-21
KR19990082999A (ko) 1999-11-25
BR9903179A (pt) 2000-05-09
CN1236645A (zh) 1999-12-01

Similar Documents

Publication Publication Date Title
FI973828L (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
YU49315B (sh) Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
FI970522A7 (fi) Koostumukset ja menetelmät pidennetyn paikallisanestesian aikaansaamis eksi
YU53098A (sh) Preparat koncentrovanog antitela
BR9509710A (pt) Composições para hemorróidas e método de uso
ATE247470T1 (de) Neue substituierte imidazolverbindungen
GT199700009A (es) Terapia combinada para la osteoporosis.
NO971568L (no) Analoger av keratinocyttvekstfaktor
EP0843592A4 (en) DEHALOGENATION OF HYDROCARBONS PRESENT IN AQUEOUS COMPOSITIONS
ECSP941120A (es) Derivados de 1,5 benzodiazepina
ES2132556T3 (es) Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
AR010636A1 (es) COMPOSICION BIOCIDA ALQUIDICA, CONCENTRADO DE LA MISMA, FORMULACIoN DE RECUBRIMIENTO Y MÉTODO PARA ESTABILIZAR LA ACTIVIDAD BIOCIDA.
BR9706902A (pt) Uso de pelo menos um inibidor da atividade do ácido retinóico e composição
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
AR020064A1 (es) Composicion farmaceutica que contiene una combinacion de una proteina osteoinductiva y un factor de dorsalizacion y metodo para su elaboracion.
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
CO4930269A1 (es) Composiciones farmaceuticas
FI952738L (fi) Stabiiliproteiini, fosfolipidikoostumuksia ja menetelmiä
FI964113L (fi) Lääkekoostumus hoitamaan tardiivia dyskinesiaa ja sen käyttö
EA200000112A1 (ru) Новая композиция